Schonfeld Strategic Advisors’s Medifast MED Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$131K	Sell	12,367 -30,185	-71%	-$348K	﹤0.01%	2267
2026 Q1	$434K	Buy	+42,552	New	+$459K	﹤0.01%	1447
2024 Q3	–	Sell	-10,318	Closed	-$225K	–	2256
2024 Q2	$225K	Buy	+10,318	New	+$275K	﹤0.01%	1779
2023 Q3	–	Sell	-9,520	Closed	-$877K	–	2083
2023 Q2	$877K	Buy	9,520 +1,720	+22%	+$153K	0.01%	1020
2023 Q1	$809K	Buy	7,800 +5,400	+225%	+$598K	0.01%	1023
2022 Q4	$277K	Sell	2,400 -1,600	-40%	-$186K	﹤0.01%	1834
2022 Q3	$433K	Sell	4,000 -19,300	-83%	-$2.77M	﹤0.01%	1851
2022 Q2	$4.21M	Buy	+23,300	New	+$4.17M	0.04%	521
2019 Q3	–	Sell	-6,300	Closed	-$808K	–	1147
2019 Q2	$808K	Buy	+6,300	New	+$875K	0.03%	503

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Schonfeld Strategic Advisors's MED Position: Q2 2026 in Review

Schonfeld Strategic Advisors reduced its Medifast (MED) stake by 71% in Q2 2026, selling an estimated $348K and leaving 12,367 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #2267.

Schonfeld Strategic Advisors first reported a position in MED in Q2 2019 and has held it in 9 quarters since. The position peaked at $4.21M in Q2 2022. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Schonfeld Strategic Advisors held 12,367 shares of Medifast worth $131K as of Q2 2026.
Schonfeld Strategic Advisors sold 30,185 Medifast shares in Q2 2026, an estimated $348K.
Medifast made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2267 holding.
Schonfeld Strategic Advisors first reported a position in Medifast in Q2 2019 and has held it in 9 quarters since.
Schonfeld Strategic Advisors's Medifast position peaked at $4.21M in Q2 2022.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.